Medtronic, Inc.

St. Jude Medical Ab

Richard Sutton

Ivan M Bourgeois

Rolf Vetter

Nathalie Virag

Karl D Dulk

Loek Herpers

It has been discovered that a change in posture that results in an increase in orthostatic stress, when followed by a withdrawal of sympathetic nervous activity, may indicate a future onset of vasovagal syncope (VVS). The invention is directed to devices and techniques for early detection of an episode of VVS so that therapies may be applied in advance of the episode to prevent the episode from occurring. Detection of a posture transition triggers a device such as an implanted pacemaker to determine an indicator of an autonomic nervous system activity of the patient. As a function of this determination, the device estimates a probability that the patient will experience VVS. When the probability exceeds a threshold, preventative therapy may be applied to address the VVS and to reduce the risk that the patient will faint.

Detection of vasovagal syncope

A temporary balloon-type electrode for insertion and temporary fixation in a blood vessel of a heart, for determining a suitable place therein for a subsequently inserted and fixed permanent electrode, has a catheter and an inflatable and deflatable balloon member disposed at a distal end portion of the catheter. The balloon member has at least one radially expandable hollow body. At least one electrode surface contact member is disposed at a peripheral portion of the hollow body, and flow passages are provided for allowing a blood flow to pass the balloon member when inflated. The temporary balloon-type electrode is particularly suited for use in coronary sinus and peripheral coronary veins of the heart.

Inflatable electrode for temporary pacing

The invention relates to a method and apparatus for minimizing calcification of a heart valve wherein electric energy is supplied to the heart in the region of the aortic valve during the refractory period of the heart.

Method and apparatus for inhibiting or minimizing calcification of aortic valves

The present invention provides an ablation lead for treating atrial flutter wherein the tip of the lead is fixed in the patient's heart by screwing and wherein the electrodes are arranged on the lead so as to overlie the area between the tricuspid annulus and the inferior vena cava. Radiofrequency energy is applied through the electrodes to cause ablation of the tissue. With the tips screwed in position, the lead can then be manipulated so that the RF energy can be applied to the area between the coronary sinus the tricuspid annulus to cause ablation of the tissue in that area also.

Ablation lead for atrial flutter

Cardiac pacemaker with hystersis behavior

A device for treating sleep apnea comprising means for detecting an apnea event and means responsive to detection of an apnea event for stimulating the heart at a higher rate than the heart's natural rate.

Apparatus for management of sleep apnea

A pacemaker having a hysteresis feature which permits intrinsic heart activity, controlled by the sinus node to resume optimally after pacing. The pacemaker has a programmable lower rate and upper rate, a programmable lower hysteresis rate (LRH) corresponding to a lower rate hysteresis interval (LRHI), and a programmable rate (IR) intermediate an upper pacing rate (UR) and a lower pacing rate (LR). A microprocessor measures the average rate of change M.sub.AVG in the intervals between consecutive ventricular depolarizations, and compares the last intrinsic escape interval RR.sub.N to the lower rate hysteresis interval (LRHI). If the last intrinsic escape interval RR.sub.N is longer than the lower rate hysteresis interval (LRHI), and if the value of M.sub.AVG is greater than a first preselected value SL.sub.1 but less than a second preselected value SL.sub.2, the pacemaker stimulates at the lower rate hysteresis (LRH) and thereafter gradually increases the pacing rate up to the intermediate rate (IR). A time counter maintains a continuous pacing at the intermediate rate (IR) for a predefined period of time, and the pacing rate is gradually decreased toward the lower pacing rate (LR).

Cardiac pacemaker with hysteresis behavior

A cardiac pacemaker and related pacing method. The cardiac pacemaker includes atrial and ventricular sense amplifiers for generating atrial and ventricular sense signals. An activity control circuit measures the activity level and initiates an activity interval. A control circuit responds to the atrial sense signals, the ventricular sense signals, and the activity control circuit, for controlling the atrial and ventricular stimuli generation, by matching the activity interval with the depolarization of the atrial tissue, in order to differentiate true exercise induced sinus tachycardia from atrial arrhythmias and retrograde atrial events, and to permit a selective ventricular rate control. The control circuit initiates a 2 to 1 ventricular to atrial response when the activity interval is greater than a VV interval, which is the sum of the interval between the last sensed or paced ventricular event and the atrial intrinsic depolarization (VA.sub.S interval) and the programmed AV delay or the sensed AV interval. The 2 to 1 block mode is induced by prolonging the post ventricular atrial refractory period (PVARP) for the next beat.

Growing community of inventors

London, United Kingdom

Richard Sutton